India recommends nod to SII for phase 2/3 trials of Covid-19 vaccine Covovaxon children
NEW DELHI: An expert panel of India's Central Drug Authority on Tuesday recommended granting permission to Serum Institute of India...
NEW DELHI: An expert panel of India's Central Drug Authority on Tuesday recommended granting permission to Serum Institute of India...